Cole Hugh M
Insider CIK 1604646 · CATB Director · JNCE Chief Operating Officer · ARIA SVP, Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 16,666 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 26,550 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 8,333 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 26,550 | — | $0 | 26,550 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2023-06-02 | 2023-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2023-01-10 | 2023-01-11 | 9,182 | $1.12 | $10.3K | 110,082 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2023-01-09 | 2023-01-11 | 7,452 | $1.10 | $8.2K | 119,264 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2022-08-01 | 2022-08-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2022-08-01 | 2022-08-03 | 20,000 | — | $0 | 126,716 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-09 | 8,333 | — | $0 | 8,333 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-21 | 8,333 | — | $0 | 8,333 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-02-03 | 85,000 | — | $0 | 85,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-03-17 | 85,000 | — | $0 | 85,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2022-02-01 | 2022-02-03 | 42,500 | — | $0 | 106,716 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2022-01-10 | 2022-01-11 | 6,205 | $6.65 | $41.3K | 64,216 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2022-01-07 | 2022-01-11 | 3,468 | $7.30 | $25.3K | 70,421 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2021-06-02 | 2021-06-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2021-02-01 | 2021-02-03 | 53,400 | $11.89 | $634.9K | 53,400 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2021-02-01 | 2021-02-03 | 26,700 | — | $0 | 73,889 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2021-01-22 | 2021-01-25 | 5,000 | — | $0 | 39,500 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise deriv | 2021-01-22 | 2021-01-25 | 5,000 | — | $0 | 55,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-22 | 2021-01-25 | 18,000 | $11.95 | $215.1K | 47,189 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2021-01-22 | 2021-01-25 | 5,000 | $6.55 | $32.8K | 65,189 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | M Exercise | 2021-01-22 | 2021-01-25 | 5,000 | $4.40 | $22.0K | 60,189 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-08 | 2021-01-11 | 3,340 | $7.00 | $23.4K | 55,189 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-01-07 | 2021-01-11 | 2,879 | $6.76 | $19.5K | 58,529 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-08-18 | 2020-08-18 | 744 | $4.71 | $3.5K | 61,408 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-08-17 | 2020-08-18 | 454 | $4.86 | $2.2K | 62,152 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-08-14 | 2020-08-18 | 984 | $4.64 | $4.6K | 62,606 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2020-06-11 | 2020-06-12 | 7,500 | — | $0 | 7,500 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2020-02-03 | 2020-02-04 | 60,000 | — | $0 | 60,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2020-02-03 | 2020-02-04 | 30,000 | — | $0 | 63,590 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-01-07 | 2020-01-10 | 2,624 | $7.78 | $20.4K | 33,590 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2019-08-16 | 2019-08-16 | 1,018 | $3.92 | $4.0K | 36,214 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2019-08-15 | 2019-08-16 | 648 | $4.00 | $2.6K | 37,232 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2019-08-14 | 2019-08-16 | 670 | $4.10 | $2.7K | 37,880 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2019-07-26 | 2019-07-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2019-02-01 | 2019-02-05 | 44,500 | — | $0 | 44,500 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2019-02-01 | 2019-02-05 | 22,250 | — | $0 | 38,550 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award | 2018-08-13 | 2018-08-15 | 14,400 | — | $0 | 16,300 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | P Buy | 2018-06-15 | 2018-06-18 | 1,900 | $7.84 | $14.9K | 1,900 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 70,500 | — | $0 | 70,500 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 78,000 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 100,000 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 64,733 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer deriv | 2017-02-16 | 2017-02-16 | 9,788 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | D To issuer | 2017-02-16 | 2017-02-16 | 42,834 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2017-02-06 | 2017-02-07 | 9,788 | — | $0 | 9,788 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | S Sale | 2016-06-28 | 2016-06-29 | 6,012 | $7.05 | $42.4K | 29,916 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | M Exercise deriv | 2016-06-27 | 2016-06-29 | 12,500 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | M Exercise deriv | 2016-06-27 | 2016-06-29 | 6,666 | — | $0 | 6,667 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | M Exercise | 2016-06-27 | 2016-06-29 | 12,500 | — | $0 | 29,262 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | M Exercise | 2016-06-27 | 2016-06-29 | 6,666 | — | $0 | 35,928 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | M Exercise deriv | 2016-04-29 | 2016-05-02 | 17,334 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | F Tax w/h | 2016-04-29 | 2016-05-02 | 5,634 | $7.18 | $40.5K | 16,762 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | M Exercise | 2016-04-29 | 2016-05-02 | 17,334 | — | $0 | 22,396 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | M Exercise deriv | 2016-03-16 | 2016-03-18 | 7,500 | $6.21 | $46.6K | 7,500 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2016-03-16 | 2016-03-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | M Exercise | 2016-03-16 | 2016-03-18 | 7,500 | $6.21 | $46.6K | 7,500 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | F Tax w/h | 2016-03-16 | 2016-03-18 | 2,438 | $6.21 | $15.1K | 5,062 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2016-03-07 | 2016-03-09 | 78,000 | $6.51 | $507.8K | 78,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2016-03-07 | 2016-03-09 | 23,400 | — | $0 | 23,400 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | M Exercise deriv | 2015-06-25 | 2017-02-07 | 6,667 | — | $0 | 6,667 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | M Exercise deriv | 2015-06-25 | 2017-02-07 | 12,500 | — | $0 | 0 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | M Exercise | 2015-06-25 | 2017-02-07 | 6,667 | — | $0 | 49,083 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | M Exercise | 2015-06-25 | 2017-02-07 | 12,500 | — | $0 | 42,416 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | F Tax w/h | 2015-06-25 | 2017-02-07 | 6,249 | $8.69 | $54.3K | 42,834 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2015-04-29 | 2015-04-30 | 52,000 | — | $0 | 52,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2014-06-25 | 2014-06-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2014-06-25 | 2014-06-27 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ARIA ARIAD PHARMACEUTICALS INC | A Award deriv | 2014-06-25 | 2014-06-27 | 25,000 | — | $0 | 25,000 | SEC↗ |